Kindmans Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 25-06-2024
- Paid Up Capital ₹ 1.50 M
as on 25-06-2024
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
About Kindmans Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Bipin Jena, Famidanaj Perween, Mohammed Haque, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239KA2022PLC156976
- Company No.
156976
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Jan 2022
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kindmans Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohammed Haque  | Managing Director | 24-Jan-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bipin Jena | Director | 24-Jan-2022 | Current |
| Famidanaj Perween | Director | 24-Jan-2022 | Current |
| Mohammed Haque | Director | 24-Jan-2022 | Current |
| Muralikrishna Neelakantan | Director | 21-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of Kindmans Laboratories.
Enhance accessibility to Kindmans Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Kindmans Laboratories?
Unlock access to Kindmans Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mubin Pharmaceuticals Private Limited
Active
3 years 6 months Famidanaj Perween, Mohammed Haque and 1 more are mutual person
Mk Infrastructures (India) Private Limited
Active 21 years 6 months Mohammed Haque is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kindmans Laboratories?
Kindmans Laboratories has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kindmans Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kindmans Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
